Healthcare real estate investment trust Ventas, Inc. (VTR) Thursday reported a decline in profit for the third quarter, reflecting higher charges and merger related expenses as well as the absence of a gain realized in the prior-year quarter. The company also raised its normalized FFO guidance for the fiscal 2009.
Net income attributable to shareholders for the quarter declined to $49.80 million or $0.32 per share from $63.77 million or $0.45 per share in the comparable quarter last year.
Results for the quarter include depreciation and amortization charges of $50.18 million and merger-related expenses and deal costs of $5.89 million.
FFO for the quarter was down 13% to $98.3 million, from $113.0 million in the prior year, while FFO per share decreased 21.3% to $0.63, from $0.80 a year earlier due primarily to the reversal of a $23.3 million previously recorded contingent liability, offset by a $6.0 million valuation allowance on real estate mortgage loans receivable recorded during the third quarter of 2008, the company said.
Normalized FFO, which adjusts for special items, was $103.39 million or $0.66 per share, up 7.4% compared to $96.23 million or $0.68 per share in the previous year. Funds available for distribution were $98.36 million or $0.63 per share, compared to $89.94 million or $0.64 per share a year ago.
On average, 12 analysts polled by Thomson Reuters expected the company to report earnings of $0.63 per share. Analysts' estimates typically exclude special itmes.
Total revenues for the quarter edged up to $235.83 million from $235.12 million last year. Analysts estimated a revenue of $231.90 million for the third quarter.
Rental income rose to $126.00 million from $121.17 million in the previous year. Resident fees and services were $106.51 million, compared to $108.61 million a year ago. Income from loans and investments declined to $3.21 million from $3.43 million last year. Interest and other income were $0.10 million, down from $1.91 million in the previous year.
Total expenses for the quarter were $185.93 million, compared to $195.61 million a year ago.
For the nine-month period, net income increased to $212.41 million or $1.40 per share from $165.07 million or $1.19 per share in the same period of the previous year. FFO for the period was $289.37 million or $1.91 per share, compared to $314.76 million or $2.27 per share in the year ago period. Total revenues for the period rose to $697.26 million from $691.44 million last year.
Looking forward, the company expects normalized FFO to be in the range of $2.62 to 2.65 per share, compared to the previous guidance in the range of $2.55 to $2.62 per share for the fiscal 2009. Analysts currently expect earnings of $2.60 per share on revenues of $922.97 million for the full year.
VTR is currently trading at $40.11, up 1.10 or 2.79%, on a volume of 446K shares on the NYSE.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.